RNAi Screen and Proteomics Reveal NXF1 as a Novel Regulator of IRF5 Signaling
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RNAi Screen and Proteomics Reveal NXF1 as a Novel Regulator of IRF5 Signaling
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-26
DOI
10.1038/s41598-017-02857-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease
- (2016) Hayley L. Eames et al. Translational Research
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Proteasome inhibitors as experimental therapeutics of autoimmune diseases
- (2015) Sue Verbrugge et al. ARTHRITIS RESEARCH & THERAPY
- TRIM32 Senses and Restricts Influenza A Virus by Ubiquitination of PB1 Polymerase
- (2015) Bishi Fu et al. PLoS Pathogens
- IRF5-mediated signaling and implications for SLE
- (2014) Elisa Lazzari et al. CLINICAL IMMUNOLOGY
- IKKβ is an IRF5 kinase that instigates inflammation
- (2014) Junyao Ren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells
- (2014) Marta Lopez-Pelaez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postage for the messenger: designating routes for nuclear mRNA export
- (2013) Barbara J. Natalizio et al. TRENDS IN CELL BIOLOGY
- Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
- (2012) Candace M. Cham et al. Clinical & Developmental Immunology
- The COP9 Signalosome Interacts with and Regulates Interferon Regulatory Factor 5 Protein Stability
- (2012) Justyna Korczeniewska et al. MOLECULAR AND CELLULAR BIOLOGY
- Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons
- (2011) Rivka C. Stone et al. ARTHRITIS AND RHEUMATISM
- Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells
- (2011) H. Travis Ichikawa et al. ARTHRITIS AND RHEUMATISM
- Mapping a Dynamic Innate Immunity Protein Interaction Network Regulating Type I Interferon Production
- (2011) Shitao Li et al. IMMUNITY
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- SAINT: probabilistic scoring of affinity purification–mass spectrometry data
- (2010) Hyungwon Choi et al. NATURE METHODS
- NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis
- (2009) Amit K. Pandey et al. PLoS Pathogens
- Functional Regulation of MyD88-Activated Interferon Regulatory Factor 5 by K63-Linked Polyubiquitination
- (2008) M. Y. Balkhi et al. MOLECULAR AND CELLULAR BIOLOGY
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- The COP9 signalosome: more than a protease
- (2008) N WEI et al. TRENDS IN BIOCHEMICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started